Finance Watch: Prepare For September IPOs To Rebound From August Slowdown
H1 Saw $10.2bn In COVID-19 Financings
Renaissance Capital expects an initial public offering surge in September; Biomedtracker data show financings for COVID-19 programs fell from Q1 to Q2; Revelation will merge with a special purpose acquisition corporation; Ascendis netted $379.3m in a follow-on offering; and Disc Medicine raised $90m in venture capital.
